期刊文献+

来曲唑联合达因35治疗多囊卵巢综合征引发不孕的疗效观察 被引量:2

Clinical Study on Infertile with Polycystic Ovary Syndrome with letrozole and Diane 35
下载PDF
导出
摘要 目的探讨达因35联合来曲唑对有生育要求的多囊卵巢综合征(PCOS)患者促排卵治疗的效果。方法将59例有生育要求的PCOS患者分为2组,无胰岛素抵抗患者30例(A组),有胰岛素抵抗患者29例(B组)。先行基础治疗:A组自月经周期第5天起口服达因351片/d,3个月1个疗程,第2个疗程为1个月;B组连服用达因35方案同A组,加服二甲双胍0.5g/次,3次/d。促排卵治疗:2组在月经周期第5天起服用来曲唑2.5mg,连用5d,逐月增加2.5mg/d不超过3个周期,直至卵泡直径>19mm,对不能排卵患者用HCG5000~10000U肌注促其排卵。对2组基础治疗效果及排卵率进行比较。结果2组基础治疗均有效,黄体生成素(LH)、LH/FSH及睾酮(T)与治疗前比较,差异均有统计学意义(均P<0.05);2组排卵率分别是93.3%和89.6%,差异无统计学意义(P>0.05)。结论来曲唑联合达因35治疗对有生育要求的PCOS患者的促排卵治疗有良好的效果。 Objective To evaluate the effect on infertile patients of polycystic ovarian syndrome(PCOS) treated to stimulated ovulation by Letrozole and Diane 35.Methods 59 infertility patients with PCOS were divided into 30 cases of A group and 29 cases of B group,A group was PCOS only,B group was PCOS and insulin resistance(IR).Basic treatment first:A groups received Diane 35 1p/d for three months during days 5 of menstrual circle,then for one month;B groups received the same,and added metformin 0.5 g/d(divided 3 times).then treated to induced ovulation:two groups all received letrozole 2.5 g/d for five days during days 5 of menstrual circle,added 2.5 g/d every month until the third month or the diameter of the biggest follicle reached 19 mm.if can not ovulate,5000~10 000 U HCG was injected to trigger ovuliaion.To contrast the effectand ovulation rate between two groups.Results The basic treatment of two groups all can attain good effect,LH,LH/FSH and T all have statistical difference(P〈0.05 )after treatment.The ovulation rate of A group was 93.3% and B group was 89.6%,this result has no significant(〈0.05 ).Conclusions The infertile patients of PCOS were treated to good results with Letrozole and Diane 35.
作者 李惠梅
出处 《江西医学院学报》 2009年第9期64-66,69,共4页 Acta Academiae Medicinae Jiangxi
关键词 多囊卵巢综合征 达因35 来曲唑 胰岛素抵抗 polycystic ovary syndrome Diane 35 Letrozole insulin resistance
  • 相关文献

参考文献8

二级参考文献30

  • 1于传鑫,李诵炫.多囊卵巢综合征.实用妇科内分泌学.第2版,上海:复旦大学出版社,2004:150 被引量:3
  • 2Ghina G,William HK ,Michael BA,et al. Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystid ovary syndrome. Fertil Steril ,2003 ,79 :562-566. 被引量:1
  • 3Yildiz BO,Knochenhauer ES,Azziz R. Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab,2007, Oct 9. 被引量:1
  • 4Lam PM,Johnson IR, Raine-Fenning NJ. Three dimensional ultrasound features of the polycystic ovary and the effect of different phenotypic expressions on these parameters. Hum Repn:M ,2007 ,Oct 18. 被引量:1
  • 5Dunalf,A. Insulin resistance and the polycystic ovary syndrome:mechanism and implications for pathogenesis. Endocr Rev ,1997 ,18 ,774-800. 被引量:1
  • 6Apridonidze T, Essah PA, Iuomo MJ,et al. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab,2004,90:1929-1945. 被引量:1
  • 7Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome ,towards a rational approach//Dunaif A, Givens JR,Haseltine F, et al. Polycystic ovary syndrome. Boston: Blackwell scientific publications, 1992:377-384. 被引量:1
  • 8The Rotterdann ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome(PCOS). Hum Reprod,2004, 19:41-47. 被引量:1
  • 9Dunaif A. Insulin resistance and ovarian hyperandrogenism. Endocrinologist, 1992,2:248-260. 被引量:1
  • 10Clark AM,Thomley B ,Tomlinson L,et al. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod ,1998 ,13 : 1502-1505. 被引量:1

共引文献52

同被引文献14

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部